Morphosy Licensing Partner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Morphosy Licensing Partner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Morphosy Licensing Partner Today - Breaking & Trending Today

GSK, MorphoSys' Licensing Partner, Provides Update on ContRAst Phase III Program for Otilimab in Moderate to Severe Rheumatoid Arthritis

Published: October 27, 2022

EQS-News: MorphoSys AG / Key word(s): MiscellaneousGSK, MorphoSys’ Licensing Partner, Provides Update on ContRAst Phase III Program for Otilimab in Moderate to Severe Rheumatoid Arthritis   27.10.2022 / 08:50 CET/CESTThe issuer is solely responsible for the content of this announcement.Media ReleasePlanegg/Munich,...

Source: pharmiweb.com

Related Topics:

United StatesThomas BiegiJulia NeugebauerEamonn NolanExchange CommissionAmerican College Of RheumatologyProgram For OtilimabDistribution ServicesMorphosy Licensing PartnerProvides UpdateSevere Rheumatoid ArthritisSevere RheumatoidAmerican CollegeJanus KinaseMorphosy Annual ReportCorporate NewsRegulatory Announcements